ABPMR Neuromuscular Medicine Practice Questions - ABPMR Neuromuscular Medicine Subspecialty Certifying Examination Exam

Which disease-modifying therapy for ALS is specifically indicated only in patients with confirmed SOD1 gene mutations?

Tofersen Riluzole Edaravone AMX0035 (sodium phenylbutyrate-taurursodiol)

Correct Answer:

Tofersen

Access more questions from this quiz

Continue to ABPMR Neuromuscular Medicine Practice Questions - ABPMR Neuromuscular Medicine Subspecialty Certifying Examination Exam for more practice questions and the full quiz experience.

Access More Questions